- Mots-clés > antiretroviral therapy (ART)
- Mots-clés > antiretrovirals
- Mots-clés > children - antiretroviral therapy
- Mots-clés > HIV - mother-to-child transmission (MTCT)
- Mots-clés > HIV/AIDS related treatment
- Mots-clés > national treatment guidelines
- Mots-clés > opportunistic infections and other HIV-related
- Mots-clés > treatment guidelines
(2003; 49 pages)
In 1986, first antiretroviral therapy was introduced and the first drug was Zidovudine (ZDV). Over the next few years, other antiretroviral drugs (NsRTIs, NNRTIs) and PIs were introduced. Initially, mono and dual therapies were used but there was problem of resistance. At present, 3 or more ARV drugs are recommended worldwide for the treatment of people with HIV infection. Since the use of combination therapy, this disease has been transformed into chronic condition. However, the use of antiretroviral therapy is not all in all solution in HIV/AIDS prevention and care program. The delivery of effective care and antiretroviral treatment for people living with HIV/AIDS in poorest countries is considered as an urgent priority and seems as a complement program to prevent HIV transmission. Initially, antiretroviral therapy was very expensive and unaffordable in most of developing countries. As drugs are increasingly available at affordable cost, the development of guidelines on the appropriate and rationale use of ART have been relevant in developing countries.
The current guidelines are intended basically for use by medical doctors who use ARV therapy to the people infected with HIV/AIDS. Guidelines for the treatment and management of HIV infection have been produced in a number of countries in Europe, Australia, USA, India, Thailand, etc. and by WHO/UNAIDS. While the guidelines attempt to represent the current state of knowledge, it is inevitable that, as HIV/AIDS is a rapidly evolving medical field, new data will change therapeutic choices and preferences...